---
title: Dexmedetomidine
date: '2023-02-02'
type: page
weight: 1521
commentable: true
show_breadcrumb: true
tags: 
    - Dexmedetomidine
    - Hypnotics
authors: 
    - Justin Hefley
    - Lauren Suszan
bannerColor: "yellow"
---

Priming Dose: **0.5 - 1 mcg/kg over 10 min**  
Infusion Dose: **0.2 - 0.7 mcg/kg/hr**  
Onset: **5 - 10 minutes**  
Peak: **25 minutes**  
Duration: **2 hours**  
Elimination: **Hepatic**  
Mechanism of Action: **Selective {{< math >}}$\alpha_2${{< /math >}} adrenergic agonist**  

- {{< math >}}$\alpha_2 > \alpha_1${{< /math >}} 1600:1
- {{< math >}}t$\frac{1}{2}\alpha${{< /math >}} = 6 min
- 8x more specific to {{< math >}}$\alpha_2${{< /math >}} than clonidine
- lipophylic a-methylol derivative
- Bradycardia
- Xerostomia (antisialagogue)
- Protein Binding 94%
- Paradoxical hypertension with bolus doses can be seen from stimulation of {{< math >}}$\alpha_{2B}${{< /math >}} subtype in vascular smooth muscle.
- Hypotension
- Useful for awake fiberoptic
- Decreases MAC by 20 - 40%
- Sedative effects are mediated by {{< math >}}$\alpha_2${{< /math >}} receptors in locus ceruleus and spinal cord making it useful for patients with PTSD
- {{< math >}}$CO_2${{< /math >}} response preserved.



##### Bibliography
[^6], [^15], [^16], [^14]



[^1]:<span style="color:blue">Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC, Ortega R, Sharar SR, Holt NF, eds. Clinical Anesthesia. 8th edition. Wolters Kluwer; 2017.</span>
[^2]: <span style="color:purple">Chestnut DH, Wong CA, Tsen LC, Ngan Kee WD, Beilin Y, Mhyre JM, Bateman BT, eds. 6th edition. Elsevier; 2020.</span>
[^3]: <span style="color:pink">Coté CJ, Lerman J, Anderson BJ. Coté and Lerman's A Practice of Anesthesia for Infants and Children. 6th edition. Elsevier; 2018.</span>
[^4]: <span style="color:brown">Ehrenwerth J, Eisenkraft J, Berry J, eds. Anesthesia Equipment: Principles and Applications. 3rd edition. Elsevier; 2020.</span>
[^5]: <span style="color:green">Farag E, Mounir-Soliman L, Brown DL. Brown's Atlas of Regional Anesthesia. 6th edition. Elsevier; 2020.</span>
[^6]: <span style="color:red">Flood P, Rathmell JP, Urman RD, eds. Stoelting's Pharmacology & Physiology in Anesthetic Practice. 6th edition. Wolters Kluwer; 2021.</span>
[^7]: <span style="color:yellow">Foster SD, Callahan MF, eds. A Professional Study and Resource Guide for the CRNA. 2nd edition. American Association of Nurse Anesthetists; 2011.</span>
[^8]: <span style="color:orange">Gropper MA, Cohen NH, Eriksson LI, Fleisher LA, Leslie K, Wiener-Kronish JP, eds. Miller's Anesthesia (Vols. 1-2). 9th edition. Elsevier; 2019.</span>
[^9]: <span style="color:indigo">Rosenblatt WH, Popescu WM. Master Techniques in Upper and Lower Airway Management. Wolters Kluwer (LWW); 2015.</span>
[^10]: <span style="color:teal">Hall JE, Hall ME. Guyton and Hall Textbook of Medical Physiology. 14th edition. Elsevier; 2020.</span>
[^11]: <span style="color:maroon">Hines RL, Jones SB, eds. Stoelting's Anesthesia and Co-existing Disease. 8th edition. Elsevier; 2021.</span>
[^12]: <span style="color:aquamarine">Jaffe RA, Schmiesing CA, Golianu B. Anesthesiologist's Manual of Surgical Procedures. 6th ed. Wolters Kluwer; 2020.</span>
[^13]: <span style="color:darkgreen">Nagelhout JJ, Elisha S, Heiner JS, eds. Nurse Anesthesia. 7th edition. Elsevier; 2020.</span>
[^14]: Bruder EA, Ball IM, Ridi S, Pickett W, Hohl C. Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients. Cochrane Database Syst Rev. 2015;1(1):CD010225. doi:10.1002/14651858.CD010225.pub2
[^15]: Evers AS, Maze M, Kharasch ED, eds. Anesthetic Pharmacology ; [Basic Principles and Clinical Practice]. 2. ed. Cambridge Univ. Press; 2011.
[^16]: Forman SA, Warner DS. Clinical and Molecular Pharmacology of Etomidate. Anesthesiology. 2011;114(3):695-707. doi:10.1097/ALN.0b013e3181ff72b5
